Targeting the Cdc2‐like kinase 2 for overcoming platinum resistance in ovarian cancer
Yingxin Jiang(Sun Yat-sen University), Min Zheng(Guangzhou University of Chinese Medicine), Jundong Li(University of Virginia), Baoyue Pan(Sun Yat-sen University), Rongzhen Luo(Sun Yat-sen University), Wei‐Hua Jia(Sun Yat-sen University), Ting Wan(Guangzhou University of Chinese Medicine), Shenjiao Huang(Sun Yat-sen University), Xiaojing Zheng(Case Western Reserve University), Mingxiu Ju(Sun Yat-sen University), Lan Zhang(Sun Yat-sen University), Pingping Liu(Qingdao University), Yun Zhou(Fujian Medical University), Yi Ouyang(Sun Yat-sen University), Huiling Xiang(Tianjin Third Central Hospital), Haifeng Gu(Sun Yat-sen University), Wei Zhang(Affiliated Hospital of Southwest Medical University), Shuting Huang(Taishan University)
Cited by 9
Related Papers
Feature Selection
|ACM Computing Surveys|2017|2.3k
The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation
|Molecular and Cellular Biology|2002|490
Synthesis and anticancer evaluation of bis(benzimidazoles), bis(benzoxazoles), and benzothiazoles
|Bioorganic & Medicinal Chemistry|2006|342
Gold nanoparticles and gold nanorods in the landscape of cancer therapy
|Molecular Cancer|2023|310
Line Graph Neural Networks for Link Prediction
|IEEE Transactions on Pattern Analysis and Machine Intelligence|2021|235